FARE Clinical Trial Finder
Efficacy and Safety of Three Doses of Florence Oral Suspension in Adults With Eosinophilic Esophagitis
The purpose of this study is to evaluate the efficacy of three doses of Florence oral suspension on changes of eosinophilic infiltration in esophageal biopsies.
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.
An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.
Searching Both is inclusive of interventional and observational studies.
|Eligible Ages||18 Years and Over|
- - Signed consent; - Participants aged 18 years or more; - Participants diagnosed with eosinophilic esophagitis, defined as: 1.
- - Any clinical and laboratory findings that, in the judgment of the investigator, may interfere with the safety of research participants; - Participants with a stricture on endoscopy that prevents passage of the endoscope; - History of alcohol abuse or drug use; - Use of concomitant therapies for any reason that may affect the assessment; - History of gastroesophageal surgery; - History of the abnormal gastrointestinal disorder; - Another disorder that causes esophageal eosinophilia; - Pregnancy or risk of pregnancy and lactating patients; - Participants with known allergy, contraindication or hypersensitivity to the components of the medicine used in the clinical trial; - Participation in clinical trial in the year prior to this study.
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.
Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.
Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.
Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.
The person who is responsible for the scientific and technical direction of the entire clinical study.
|Principal Investigator Affiliation||N/A|
Category of organization(s) involved as sponsor (and collaborator) supporting the trial.
|Overall Status||Not yet recruiting|
The disease, disorder, syndrome, illness, or injury that is being studied.
This trial has no sites locations listed at this time. If you are interested in learning more, you can contact the trial's primary contact:
Monalisa FB Oliveira, MD
For additional contact information, you can also visit the trial on clinicaltrials.gov.